Skip to main content

Medicine Matters diabetes


He trained in clinical diabetes at Queen’s Medical Centre, Nottingham and in research at the University of Nottingham and Washington University, St Louis, USA.  He was Editor of Diabetic Medicine from 2000-2005.  He is currently the National Speciality Lead in Diabetes to the NIHR Clinical Research Network and an NIHR Senior Investigator. He is a former member of Diabetes UK Science and Research Advisory Group, a member of the UK NIHR Programme Grants for Applied Research Panel and chairs the UK Juvenile Diabetes Research Foundation, UK Scientific Advisory Committee. 


He chairs the International Hypoglycaemia Study group, an independently funded group of international experts with a research and clinical expertise in hypoglycaemia.  The group has a remit to reduce the burden of hypoglycaemia though educational activities.


He chaired the glucose control group of the ADVANCE trial, is a steering committee member of the EXAMINE trial and was the PI on the REPOSE trial measuring the effectiveness of insulin pumps.


His research interests include the pathophysiological responses to hypoglycaemia and hypoglycaemia unawareness, the potential contribution and mechanisms of hypoglycaemia to cardiovascular mortality, the use of insulin analogues and other technologies to reduce hypoglycaemia.  He also conducts research concerned with developing programmes (including the DAFNE intervention) to encourage more effective diabetes self-management.  He has authored over 200 original research articles and reviews.


Full disclosure information 

Advisory Board Member: Eli Lilly, Novo Nordisk, Sanofi Aventis, Takeda, Zealand Pharma, UN-EEG, Boehringer Ingelheim
Consultant: Eli Lilly, Novo Nordisk,
Speaker’s Bureau: Eli Lilly, Novo Nordisk